tert-Butyl (2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethyl)carbamate, 98%, 250mg

2-chloroimidazo[1,2-a]pyridine-3-carbonitrile, 95%, 5g

2-NITRO-5-TRIFLUOROMETHYLBENZOIC ACID, 95.0%, 250mg

1-BROMO-4-METHOXY-2,3-DINITROBENZENE, 95.0%, 100mg

Symbole d'avertissement selon ISO 7010 Étiquette individuelle, Risque biologique, Longueur de côté 100 mm, 1 pièce

2-(6-Bromobenzofuran-3-yl)acetic acid, 97%, 1g

(3aR,6R,6aR)-6-(tert-Butoxymethyl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 1g

1,1,1-Trifluoro-4-(4-hydroxyphenyl)butan-2-one, 95.0%, 100mg

2-Chloroisonicotinic Acid>98.0%(HPLC)(T)5g

(2-(Morpholinomethyl)phenyl)boronic acid, 95.0%, 250mg

2,3-Difluoro-4-methylbenzonitrile, 98%, 5g

1,2-EPOXY-5-HEXENE, 95.0%, 25g

METHYL TRANS-1-BENZYL-4-CYCLOPROPYLPYRROLIDINE-3-CARBOXYLATE, 95.0%, 250mg